Oppenheimer analyst Jay Olson reiterated a Perform rating on Prothena Corp (NASDAQ: PRTA).The analyst commented: "Following the recent birtamimab miss ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE